Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL872846 | 0.91 | ALDH1A1 (0.44) | ALDH1A1NPSR1GAATSHRTDP1 | |
| SCHEMBL872973 | 0.88 | TSHR (0.48) | ALDH1A1NPSR1GAATSHRKMT2A | |
| SCHEMBL873716 | 0.87 | ALDH1A1 (0.47) | ALDH1A1NPSR1GAATSHRTDP1 | |
| SCHEMBL3917565 | 0.83 | TSHR (0.48) | ALDH1A1NPSR1TSHRSMN1; SMN2MEN1 | |
| SCHEMBL6545328 | 0.81 | ALDH1A1 (0.44) | ALDH1A1NPSR1GAASMN1; SMN2NPC1 | |
| SCHEMBL3908306 | 0.80 | SMN1; SMN2 (0.42) | ALDH1A1NPSR1TSHRSMN1; SMN2MEN1 | |
| SCHEMBL26828326 | 0.78 | THRB (0.40) | ALDH1A1NPSR1TSHRSMN1; SMN2MEN1 | |
| SCHEMBL5009517 | 0.78 | NAAA (0.45) | ALDH1A1NPSR1TSHRSMN1; SMN2CYP2C19 | |
| SCHEMBL3917383 | 0.77 | ALDH1A1 (0.47) | ALDH1A1NPSR1GAATSHRTDP1 | |
| SCHEMBL296011 | 0.77 | ALDH1A1 (0.47) | ALDH1A1NPSR1GAATSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS PBC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | disclosed |
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS, PBC | 2025-10-09 | — | — | US | disclosed |
| EP-4435080-B1 | A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE | PROCTER & GAMBLE (US) | 2025-08-20 | — | — | EP | disclosed |
| US-12371642-B2 | Benefit agent containing delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-29 | — | — | US | disclosed |
| US-20250234910-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING THIENYL ALKANOATE DERIVATIVES | OSMO LABS, PBC | 2025-07-24 | — | — | US | disclosed |
| US-20250236810-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING BENZENE DERIVATIVES | OSMO LABS, PBC | 2025-07-24 | — | — | US | disclosed |
| US-20100074971-A1 | DOUBLE PREPARATION TYPE ANTIOXIDANT COMPOSITION AND ANTIOXIDATION PRODUCT COMPRISING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-03-25 | — | — | US | disclosed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | disclosed |
| US-20090092571-A1 | LIQUID DEODORANT COMPOSITION AND DEODORIZING METHOD | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20090087401-A1 | DEODORANT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-04-02 | — | — | US | disclosed |
| EP-2042198-A1 | LIQUID DEODORANT COMPOSITION AND METHOD OF DEODORIZING | Takasago International Corporation (JP) | 2009-04-01 | — | — | EP | disclosed |
| US-20070092623-A1 | Food products containing a fruit component | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-04-26 | — | — | US | disclosed |
| EP-1689256-A1 | FOOD PRODUCTS CONTAINING A FRUIT COMPONENT | Takasago International Corporation (JP) | 2006-08-16 | — | — | EP | disclosed |
| US-20060165622-A1 | Deodorant composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-07-27 | — | — | US | disclosed |
| EP-1561476-A1 | DEODORANT COMPOSITION | Takasago International Corporation (JP) | 2005-08-10 | — | — | EP | disclosed |
| WO-2005048743-A1 | FOOD PRODUCTS CONTAINING A FRUIT COMPONENT | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CYP8B1, CYP1B1, BBOX1 | ALDH1A1 117/4885NPSR1 1283/4885GAA 2701/4885 |
| US-20250236810-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING BENZENE DERIVATIVES | BBOX1, NISCH, TAS2R4 | ALDH1A1 186/4885NPSR1 2125/4885GAA 1251/4885 |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | TAS2R42, TAS2R4, TAS2R41 | ALDH1A1 868/4885NPSR1 2821/4885GAA 1984/4885 |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | ALDH1A1 697/4885NPSR1 3699/4885GAA 1684/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | ALDH1A1 804/4885NPSR1 416/4885GAA 3289/4885 |
| US-20250234910-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING THIENYL ALKANOATE DERIVATIVES | TAS1R3, TAS2R5, TRPA1 | ALDH1A1 117/4885NPSR1 2347/4885GAA 2067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.